Luyan Pharma Co.,Ltd. (002788.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap8.26B
Enterprise Value14.61B
P/E Ratio15.13
PEG Ratio-0.99
Price/Sales Ratio0.2
Price/Book Ratio1.29
Enterprise/Revenue0.51
Enterprise/EBITDA17.21

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.01
Operating Margin0.02
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.08

Income Statement

Revenue21.25B
Revenue/Share53.61
Gross Profit1.5B
EBITDA720.39M
Net Income280.88M
Diluted EPS0.72

Balance Sheet

Total Cash555.93M
Total Cash/Share1.39
Total Debt7.18B
Total Debt/Equity2.13
Current Ratio1.11
Book Value Per Share8.48

Price History

52-Week Change30.42
52-Week High28.29
52-Week Low7.9
Moving Average 50 Days13.11
Moving Average 200 Days13.4

Statistics

Average Volume36.06M
Shares Outstanding388.52M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.35
Trailing Annual Dividend Yield3.21
Payout Ratio0.5
Last Split Factor1073:1000
Last Split DateSeptember 17, 2020
AD